RxDoctor Payments Data

Maria Wei

Dermatology · San Francisco, CANPI 1689640864

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,710 of the $8,811 with a category attached, or 76.2%. Every reported general payment came from a single manufacturer, Merck.

$8,811in general payments, 2019–2025

Across 9 payments — averaging $978.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$9K
$133,927in research payments, 2019–2025

Across 23 payments — averaging $5822.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Incyte Corporation$134K

What the payments were for

  • Consulting fees$6,71076%
  • Travel & lodging$1,93022%
  • Food & beverage$1712%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck9$8,811

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,811 in reported general payments places this provider in the 75th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California →

Medicare billing

Part B allowed, 2024
$116,637
Medicare patients
437
Services billed
2,177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast11$61,766
Fluorouracil22$1,530
Triamcinolone Acetonide79$828
Metronidazole11$809
Betamethasone Dipropionate17$648
Fluocinonide15$641
Gabapentin20$322
Ketoconazole31$301
Hydrocortisone15$300
Doxycycline Hyclate17$165
ValacyclovirValacyclovir Hcl18$148
Minoxidil14$121

Paid to pharmacies, not to this prescriber.

Other dermatology in San Francisco

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →